These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 24350616)
1. High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines. Grover A; Troudt J; Foster C; Basaraba R; Izzo A Immunology; 2014 May; 142(1):111-23. PubMed ID: 24350616 [TBL] [Abstract][Full Text] [Related]
2. Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis. Kebriaei A; Derakhshan M; Meshkat Z; Eidgahi MR; Rezaee SA; Farsiani H; Mosavat A; Soleimanpour S; Ghazvini K Mol Biol Rep; 2016 Sep; 43(9):911-22. PubMed ID: 27251218 [TBL] [Abstract][Full Text] [Related]
3. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv. Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109 [TBL] [Abstract][Full Text] [Related]
4. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis. Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285 [TBL] [Abstract][Full Text] [Related]
5. Immunological characteristics of Mycobacterium tuberculosis subunit vaccines immunized through different routes. Lu Y; Kang J; Ning H; Wang L; Xu Y; Xue Y; Xu Z; Wu X; Bai Y Microb Pathog; 2018 Dec; 125():84-92. PubMed ID: 30195646 [TBL] [Abstract][Full Text] [Related]
6. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens. Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890 [TBL] [Abstract][Full Text] [Related]
8. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy. Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020 [TBL] [Abstract][Full Text] [Related]
9. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis. Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212 [TBL] [Abstract][Full Text] [Related]
11. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant. Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059 [TBL] [Abstract][Full Text] [Related]
12. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis. Wang QM; Kang L; Wang XH Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397 [TBL] [Abstract][Full Text] [Related]
13. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice. Choi HG; Choi S; Back YW; Paik S; Park HS; Kim WS; Kim H; Cha SB; Choi CH; Shin SJ; Kim HJ Oncotarget; 2017 Mar; 8(12):19947-19967. PubMed ID: 28193909 [TBL] [Abstract][Full Text] [Related]
14. A mucosal vaccine formulation against tuberculosis by exploiting the adjuvant activity of S100A4-A damage-associated molecular pattern molecule. Abil OZ; Liu S; Yeh YW; Wu Y; Sen Chaudhuri A; Li NS; Deng C; Xiang Z Vaccine; 2024 Nov; 42(25):126151. PubMed ID: 39089961 [TBL] [Abstract][Full Text] [Related]
15. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection. Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673 [TBL] [Abstract][Full Text] [Related]
16. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536 [TBL] [Abstract][Full Text] [Related]
17. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. Xu J; Xu W; Chen X; Zhao D; Wang Y Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729 [TBL] [Abstract][Full Text] [Related]
18. In vivo electroporation of a codon-optimized BER Tang J; Cai Y; Liang J; Tan Z; Tang X; Zhang C; Cheng L; Zhou J; Wang H; Yam WC; Chen X; Wang H; Chen Z Tuberculosis (Edinb); 2018 Dec; 113():65-75. PubMed ID: 30514515 [TBL] [Abstract][Full Text] [Related]
19. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467 [TBL] [Abstract][Full Text] [Related]
20. Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex. Farsiani H; Mosavat A; Soleimanpour S; Sadeghian H; Akbari Eydgahi MR; Ghazvini K; Sankian M; Aryan E; Jamehdar SA; Rezaee SA Mol Biosyst; 2016 Jun; 12(7):2189-201. PubMed ID: 27138226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]